scispace - formally typeset
Search or ask a question
Posted ContentDOI

Acquired fluoroquinolone resistance genes in corneal isolates of Pseudomonas aeruginosa

TL;DR: Investigation of 33 strains of P. aeruginosa isolated from the cornea of microbial keratitis patients in India and Australia between 1992 and 2018 found the prevalence of acquired fluroquinolone resistance genes in ocular isolates was unclear and mutations in QRDRs and antibiotic susceptibilities to ciprofloxacin, levofloxacins and moxifloxACin were assessed to examine the association between resistance genes and phenotype.
Abstract: Fluroquinolones are widely used as an empirical therapy for pseudomonal ocular infections. Based on increasing reports on acquired fluroquinolone resistance genes in clinical isolates of Pseudomonas aeruginosa, we investigated 33 strains of P. aeruginosa isolated from the cornea of microbial keratitis patients in India and Australia between 1992 and 2018 to understand the prevalence of acquired fluroquinolone resistance genes in ocular isolates and to assess whether the possession of those genes was associated with fluoroquinolone susceptibility. We obtained the whole genome sequence of 33 isolates using Illumina MiSeq platform and investigated the prevalence of two fluoroquinolone resistance genes crpP and qnrVC1. To examine the associated mobile genetic elements of qnrVC1 positive strains, we obtained long read sequences using Oxford Nanopore MinION and performed hybrid assembly to combine long reads with Illumina short sequence reads. We further assessed mutations in QRDRs and antibiotic susceptibilities to ciprofloxacin, levofloxacin and moxifloxacin to examine the association between resistance genes and phenotype. Twenty strains possessed crpP in genetic islands characterised by possession of integrative conjugative elements. The qnrVC1 gene was carried by four isolates on class I integrons and Tn3 transposons along with aminoglycoside and beta-lactam resistance genes. We did not observe any evidence of plasmids carrying fluroquinolone resistance genes. Resistance to fluroquinolones was observed in those strains which possessed crpP, qnrVC1 and that had QRDRs mutations. The presence of crpP was not a sole cause of fluroquinolone resistance.

Summary (2 min read)

Introduction

  • Pseudomonas aeruginosa is a highly adaptable opportunistic pathogen which is ubiquitously present in the environment.
  • This bacterium is naturally resistant to many antimicrobials and can acquire antibiotic resistance through mutations in chromosomal genes and lateral gene transfer [1, 2].
  • Fluoroquinolone resistance in various clinical isolates is on the rise [7].
  • These studies were based on a single strain and the prevalence of acquired fluoroquinolone resistance genes in P. aeruginosa remains unclear.

Materials and Methods

  • Pseudomonas aeruginosa strains Isolates in this study were collected from the cornea of microbial keratitis patients in India and Australia between 1992 and 2018.
  • Information on antibiotic susceptibility and the whole genome data of 13 isolates was obtained from their previous study [23] (Supplementary Table 1).
  • DNA was sequenced on MiSeq (Illumina, San Diego, CA, USA) generating 300 bp paired end reads.
  • The core genome SNPs were used to construct a maximum likelihood phylogenetic tree.
  • Long reads were basecalled using Guppy v3.3.0 and adapters removed using Porechop v0.2.4.

Results

  • Population structure, phylogeny and fluoroquinolone resistance of P. aeruginosa strains Draft genomes were mapped against the reference genome P. aeruginosa PAO1 and a total of 202,232 SNPs were observed among the 33 isolates, which were used to construct core genome phylogeny using Parsnp v1.2 [43].
  • The detection rate of exoU was 68% in Indian isolates and 36% in Australian isolates.
  • In addition, four strains from the latter cohort of 11 strains carried another fluoroquinolone resistance gene, qnrVC1, in combination with mutations in gyrA and parC, and this was associated with a very high MIC (>128 µg/mL) to all three fluoroquinolones (Fig 1).
  • Only one of the exoU, and none of the qnrVC1 carrying strains, were positive for CRISPR-Cas genes.

Bayesian phylogenetic reconstruction

  • To examine the evolutionary trends of isolates, a Bayesian analysis was performed based on MLST sequences.
  • This study also investigated the presence of the crpP homologues in NCBI databases using local BLAST with a cut off of 80% coverage and 90% sequence identity to examine the distribution of crpP gene in the bacterial database including plasmids as of 2019-06-15.
  • Protein-coding regions are represented by the orange arrows and common key features/associated genes among all strains are shown in various coloured arrows.
  • This suggests that the qnrVC1 gene is prevalent in various bacterial families.
  • Integration of VOC with other antibiotic resistance genes leads us to hypothesise that VOC can be associated with antibiotic resistance.

Discussion

  • While fluoroquinolones are the preferred empirical therapy for corneal ulcers, which are often caused by P. aeruginosa, increasing resistance in this bacterium raises the concern about the efficacy of these antibiotics [4-11, 59, 60].
  • This result, together with finding of high divergence in crpP orthologues between strains and lower CAI compared to a highly expressed chromosomal gene (rlpS) [61] suggests that acquisition of the crpP gene was a relatively old evolutionary event in P. aeruginosa.
  • The acquired fluoroquinolone resistance gene qnrVC1 was observed in isolates sampled in 2017 and 2018, indicating that transferable fluoroquinolone resistance genes may be recently acquired or passed unnoticed in ocular isolates of P. aeruginosa.
  • Integration of several other antibiotic resistance genes in these mobile genetic elements suggests these elements may concentrate antibiotic resistance genes.
  • Given that qnrVC1 has been reported as being responsible for lowlevel fluoroquinolone resistance [18], the high MICs observed for these isolates is not clear but may indicate some synergistic activity between the QRDR mutations and qnrVC1.

Did you find this useful? Give us your feedback

Figures (5)

Content maybe subject to copyright    Report

1
Acquired fluoroquinolone resistance genes in corneal isolates of
Pseudomonas aeruginosa
Mahjabeen Khan1, Stephen Summers2, Scott A Rice2,3,4, Fiona Stapleton1, Mark D P
Willcox1, and Dinesh Subedi1,5*
1School of Optometry and Vision Science, University of New South Wales Sydney, Australia
2The Singapore Centre for Environment Life Sciences Engineering (SCELSE), Singapore
3The School of Biological Sciences, Nanyang Technological University, Singapore
4The ithree Institute, The University of Technology Sydney, Sydney, New South Wales,
Australia
5School of Biological Sciences, Monash University, Clayton, Victoria, Australia
Key words: Antimicrobial resistance, Fluroquinolones, Pseudomonas aeruginosa, eye,
corneal ulcer, microbial keratitis
* Corresponding Author: dinesh.subedi@monash.edu
(which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission.
The copyright holder for this preprintthis version posted May 21, 2020. ; https://doi.org/10.1101/2020.05.17.100396doi: bioRxiv preprint

2
Abstract
Fluroquinolones are widely used as an empirical therapy for pseudomonal ocular infections. Based on increasing
reports on acquired fluroquinolone resistance genes in clinical isolates of Pseudomonas aeruginosa, we
investigated 33 strains of P. aeruginosa isolated from the cornea of microbial keratitis patients in India and
Australia between 1992 and 2018 to understand the prevalence of acquired fluroquinolone resistance genes in
ocular isolates and to assess whether the possession of those genes was associated with fluoroquinolone
susceptibility. We obtained the whole genome sequence of 33 isolates using Illumina MiSeq platform and
investigated the prevalence of two fluoroquinolone resistance genes crpP and qnrVC1. To examine the associated
mobile genetic elements of qnrVC1 positive strains, we obtained long read sequences using Oxford Nanopore
MinION and performed hybrid assembly to combine long reads with Illumina short sequence reads. We further
assessed mutations in QRDRs and antibiotic susceptibilities to ciprofloxacin, levofloxacin and moxifloxacin to
examine the association between resistance genes and phenotype. Twenty strains possessed crpP in genetic islands
characterised by possession of integrative conjugative elements. The qnrVC1 gene was carried by four isolates on
class I integrons and Tn3 transposons along with aminoglycoside and beta-lactam resistance genes. We did not
observe any evidence of plasmids carrying fluroquinolone resistance genes. Resistance to fluroquinolones was
observed in those strains which possessed crpP, qnrVC1 and that had QRDRs mutations. The presence of crpP
was not a sole cause of fluroquinolone resistance.
Introduction
Pseudomonas aeruginosa is a highly adaptable opportunistic pathogen which is ubiquitously
present in the environment. This bacterium is naturally resistant to many antimicrobials and
can acquire antibiotic resistance through mutations in chromosomal genes and lateral gene
transfer [1, 2]. P. aeruginosa is associated with different types of human infections and because
of emerging multidrug-resistant strains, these infections are major global public health
concerns [3].
Fluoroquinolones are broad spectrum and widely prescribed antibiotics to treat pseudomonal
infections including ocular infections [4-6]. Fluoroquinolone resistance in various clinical
isolates is on the rise [7]. For example, a single centre study has shown that the prevalence of
fluoroquinolone resistance P. aeruginosa increased from 15% to 41% in ten years [8]. This
increase in fluoroquinolone resistance has been linked to the excessive use of the antibiotics
[9]. The rate of isolation of fluoroquinolone resistant strains also depends on the type of
infections; nosocomial isolates are more resistant than isolates from non-nosocomial sources
[10]. In general, fluoroquinolone resistance is relatively low in ocular isolates of P. aeruginosa
compared to other infections [11]. However, higher resistance rates have been reported in
ocular isolates in certain regions of the world and like other systemic infections this rate has
been increasing over time [12]. This has raised the concerned that the horizontal transfer of
fluoroquinolone resistance genes can be associated with spread of fluoroquinolone resistance
in ocular isolates.
Mutations that alter target sites (DNA gyrase [gyrA/gyrB] and topoisomerase IV [parC/parE])
and increased membrane permeability are common mechanisms of fluoroquinolone resistance
in P. aeruginosa [1, 13-15]. In other Gram-negative bacteria, fluoroquinolone resistance genes
such as qnr have been shown to be carried on plasmids [16, 17]. The gene encodes a
pentapeptide repeat protein which protects DNA gyrase and topoisomerase from the action of
fluroquinolones [18]. In contrast, carriage of qnr on plasmid is very rare in P. aeruginosa [19].
Despite this low carriage, recent studies have identified fluoroquinolone resistance genes in
certain mobile genetic elements. CrpP and qnrVC can be carried on the P. aeruginosa mega
plasmids pUM505 and pBM413, respectively [20, 21]. In addition, qnrVC was found to be
associated with a class I integron, which also carried beta-lactamase genes [20, 22]. These
studies were based on a single strain and the prevalence of acquired fluoroquinolone resistance
genes in P. aeruginosa remains unclear. This led us to examine mobile fluoroquinolone
resistance genes in P. aeruginosa. Given the concern of increasing fluoroquinolone resistance
(which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission.
The copyright holder for this preprintthis version posted May 21, 2020. ; https://doi.org/10.1101/2020.05.17.100396doi: bioRxiv preprint

3
in ocular isolates, we have undertaken sequence analysis of 33 ocular isolates of P. aeruginosa,
isolated from corneal ulcers in the last 25 years to assess whether the possession of
fluoroquinolone resistance genes was associated with fluoroquinolone susceptibility and
whether resistance genes carrying strains had any genetic commonalities.
Materials and Methods
Pseudomonas aeruginosa strains
Isolates in this study were collected from the cornea of microbial keratitis patients in India and Australia between 1992 and
2018. They comprise 20 isolates collected for this study and used for the antibiotic susceptibility testing and whole genome
sequencing. Information on antibiotic susceptibility and the whole genome data of 13 isolates was obtained from our previous
study [23] (Supplementary Table 1). All isolates were retrieved from the culture collection of School of Optometry and Vision
Science, the University of New South Wales, Australia without identifiable patients’ data.
Antibiotic susceptibility testing of Pseudomonas aeruginosa strains
Susceptibility of P. aeruginosa isolates to ciprofloxacin (Sigma-Aldrich, Inc., St. Louis Missouri, USA), levofloxacin (Sigma-
Aldrich, Inc.,) and moxifloxacin (European Pharmacopoeia, Strasbourg, Cedex France) was investigated using the broth
microdilution method following the protocol of Clinical and Laboratory Standard Institute [24] [25]. The MIC was taken as
the lowest concentration of an antibiotic in which no noticeable growth (turbidity) was observed and the break point was
established according to published standards [26]. Based on MICs, the isolates were categorised into four groups, susceptible
( resistance break point), resistant (> resistance break point 32 g/mL), highly resistant (> 32 128 g/mL) and very highly
resistant (>128 g/mL) for the analysis.
DNA extraction and Illumina sequencing
Bacterial DNA was extracted from overnight cultures using a DNeasy Blood and Tissue Kit (Qiagen, Hilden, Germany)
following the manufacturer’s instructions. The extracted DNA was quantified and purity-checked using Nanodrop (NanoDrop
Technologies, Wilmington, DE, USA), Qubit fluorometer (Life Technologies, Carlsbad, CA, USA), and 1% agarose gel
electrophoresis. The extracted DNA was dried for transport to the sequencing facility at Singapore Centre for Environmental
Life Sciences Engineering, Singapore. DNA was sequenced on MiSeq (Illumina, San Diego, CA, USA) generating 300 bp
paired end reads. The paired-end library was prepared using Nextera XT DNA library preparation kit (Illumina, San Diego,
CA, USA). All the libraries were multiplexed on one MiSeq run.
Bioinformatics analysis of short read sequences and construction of phylogenies
The quality of raw reads was analysed using online tool FastQC v0.117 (https://www.bioinformatics.babraham.ac.uk/projects/fastqc).
Adaptor sequences were removed using Trimmomatic v0.38 with quality and length filtering (SLIDINGWINDOW:4: 15
MINLEN:36) [27]. The reads were de-novo assembled using Spades v3.13.0 with the programs’ default setting [28] followed
by annotation using Prokka v1.12 [29]. To examine acquired resistance genes, the genomes were uploaded into online database
ResFinder v3.1 of Centre for Genomic Epidemiology, DTU, Denmark [30]. The contigs carrying crpP and qnrVC1 genes
were selected and analysed for mobile genetic elements using BLAST, Integron finder v1.5.1 [31] and IS finder [32]. The
genome was visualised and manually modified using Geneious prime v2019.2 [33]. A figure of BLAST comparison was
generated using EasyFig v2.2.2 [34]. To identify mutations in the QRDRs (gyrA, gyrB, parC and parE), the genome sequences
were analysed using Snippy v4.2 with programs default settings (https://github.com/tseemann/snippy). The genomes were
also examined for the presence of type IV secretion factors (exoU and exoS) using BLAST search, and for the presence of the
CRISPR cas system using the CRISPRcasFinder online tool [35]. Codon adaptation index (CAI) [36] was examined to
understand the possible expression of different orthologues of crpP using CAIcal [37, 38]. 50s ribosomal protein L19 (rplS),
which is a highly expressed chromosomal gene was included as the reference to show the difference in expression level
between chromosomal gene and acquired genes.
Core genome single nucleotide polymorphisms (SNPs) were identified using Parsnp v from Harvest Suite [39] using settings
to exclude SNPs identified in regions that had arisen by recombination. The core genome SNPs were used to construct a
maximum likelihood phylogenetic tree. All genomes were examined for multi-locus sequence type (MLST) using the MLST
database. Nucleotide sequences of all MLST locus were extracted and concatenated to use in Bayesian phylogenetic analyses
using BEAST2 v2.4.7 with the following parameters: gamma site heterogeneity model, Hasegawa-Kishino-Yano (HKY)
substitution model and relaxed-clock log-normal [40]. BEAST 2 output was summarized using TreeAnnotator with a 5% burn
in. The phylogenetic trees were visualised using iTol v4 [41].
MinION sequencing and analysis
Wizard Promega DNA extraction kits (Promega, Madison, WI) was used to extract DNA from overnight broth culture. DNA
was quantified and transported as mentioned above. Long reads libraries were prepared using a rapid sequencing kit (RAD-
SQK004, ONT, Oxford, UK) and subsequent sequencing was conducted using the MinIon flowcell (R9.4.1) for 48 hours.
Long reads were basecalled using Guppy v3.3.0 and adapters removed using Porechop v0.2.4. Assembly of both long and
short reads into a hybrid genome assembly was achieved with Unicycler v0.4.3 [42], opting for default parameters and using
only short reads with merging pairs. Following assembly, all assemblies were assessed for quality using Quast v5.0.2.
(which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission.
The copyright holder for this preprintthis version posted May 21, 2020. ; https://doi.org/10.1101/2020.05.17.100396doi: bioRxiv preprint

4
Results
Population structure, phylogeny and fluoroquinolone resistance of P. aeruginosa strains
Whole genomes were analysed from 33 corneal isolates of P. aeruginosa, 20 of which were
sequenced as a part of this study and 13 genome that were published previously [23]. All strains
were isolated between 1992 and 2018 in India (19 isolates) or Australia (14 isolates)
(Supplementary Table 1). Draft genomes were mapped against the reference genome P.
aeruginosa PAO1 and a total of 202,232 SNPs were observed among the 33 isolates, which
were used to construct core genome phylogeny using Parsnp v1.2 [43]. Similar to previous
reports [23, 36, 44, 45], the phylogenetic tree based on the core genome revealed two major
clades (Fig 1). These clades followed a similar pattern as for other previously described strains
of P. aeruginosa, where exoU carrying strains clustered together in a single clade (Phylogroup
2) [23]. Our results showed that 18 (of 33) isolates carried exoU, of which 16 were clustered
together in phylogroup 2, which contained predominantly Indian isolates. The detection rate of
exoU was 68% in Indian isolates and 36% in Australian isolates.
Figure 1. Maximum likelihood phylogenetic tree based on core genome SNPs analysis using
Pseudomonas aeruginosa PAO1 as the reference, excluding SNPs identified in regions that had arisen by
recombination, using the default parameters of Parsnp v1.2 [43]. Isolates from India are labelled red and
Australian isolates are labelled blue. Numbers given at the nodes represent bootstrap values. The presence
of crpP, exoU, qnrVC1, and CRISPR cas are represented by red squares. Orange squares represent the
presence of mutations in the quinolone resistance determining regions (QRDRs) and fluoroquinolone (CIP
= Ciprofloxacin; LEVO = Levofloxacin; and MOX = Moxifloxacin) susceptibilities are shown as a heat
map with the ranges indicated in the figure. The figure was drawn using iTol v4 [41].
(which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission.
The copyright holder for this preprintthis version posted May 21, 2020. ; https://doi.org/10.1101/2020.05.17.100396doi: bioRxiv preprint

5
We further examined acquired fluoroquinolone resistance genes, mutations in quinolone
resistance determining region (QRDRs), the presence of CRISPR genes and susceptibility to
three different fluoroquinolones (Fig 1). None of the Australian isolates regardless of
phylogenic grouping were resistant to fluoroquinolones. In contrast, 75% of isolates of
phylogroup 2 were resistant to at least one fluoroquinolone. Of the 33 strains, 73.7 % (14 out
of 19) of Indian and 42.8% (6 out of 14) of Australian isolates possessed crpP, which has been
recently shown to be on a plasmid (pUM505) and associated with ciprofloxacin resistance [20].
However, eight (40%) crpP carrying strains in the current study regardless of country of
isolation were not resistant to the fluoroquinolones, including ciprofloxacin (Fig 1). Eleven out
of 14 fluoroquinolone resistance strains had mutations in both gyrA and parC and all except
one carried the exoU gene. In addition, four strains from the latter cohort of 11 strains carried
another fluoroquinolone resistance gene, qnrVC1, in combination with mutations in gyrA and
parC, and this was associated with a very high MIC (>128 µg/mL) to all three fluoroquinolones
(Fig 1).
Given that exoU, crpP and qnrVC1 are components of the accessory genome which is mostly
shaped by the CRISPR-Cas system, a bacterial defence system against foreign DNA [46], we
searched isolates for CRISPR-Cas genes using the CRISPRCasFinder database [35] following
software default parameters. Only one of the exoU, and none of the qnrVC1 carrying strains,
were positive for CRISPR-Cas genes. However, CRISPR-Cas was observed in seven crpP
positive strains, which did not possess exoU and/or qnrVC1 (Fig 1).
Figure 2. Consensus tree of 33 P. aeruginosa isolates, based on Bayesian evolutionary analysis by
sampling trees (BEAST) of concatenated multi-locus sequence type (MLST) under strict clock analysis
[40]. The tip of the tree was constrained by date of isolation. The time scale is shown in years at the top
and each internal node is labelled with posterior probability limit. Isolates from India are labelled red and
Australian isolates are labelled blue. The presence of genes crpP, exoU, qnrVC1, and CRISPRcas are
represented by red squares. Orange square represents presence of mutations in quinolone resistance
determining region (QRDRs), Fluoroquinolone (CIP = Ciprofloxacin; LEVO = Levofloxacin; and MOX
= Moxifloxacin) susceptibilities are shown as heat maps in the grey scale indicated in the figure. The
figure was drawn using iTol v4 [41].
(which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission.
The copyright holder for this preprintthis version posted May 21, 2020. ; https://doi.org/10.1101/2020.05.17.100396doi: bioRxiv preprint

Citations
More filters
01 Jun 2012
TL;DR: SPAdes as mentioned in this paper is a new assembler for both single-cell and standard (multicell) assembly, and demonstrate that it improves on the recently released E+V-SC assembler and on popular assemblers Velvet and SoapDeNovo (for multicell data).
Abstract: The lion's share of bacteria in various environments cannot be cloned in the laboratory and thus cannot be sequenced using existing technologies. A major goal of single-cell genomics is to complement gene-centric metagenomic data with whole-genome assemblies of uncultivated organisms. Assembly of single-cell data is challenging because of highly non-uniform read coverage as well as elevated levels of sequencing errors and chimeric reads. We describe SPAdes, a new assembler for both single-cell and standard (multicell) assembly, and demonstrate that it improves on the recently released E+V-SC assembler (specialized for single-cell data) and on popular assemblers Velvet and SoapDeNovo (for multicell data). SPAdes generates single-cell assemblies, providing information about genomes of uncultivatable bacteria that vastly exceeds what may be obtained via traditional metagenomics studies. SPAdes is available online ( http://bioinf.spbau.ru/spades ). It is distributed as open source software.

10,124 citations

Journal ArticleDOI
TL;DR: The role of macrophage inflammatory protein-2 (MIP-2) and intercellular adhesion molecule (ICAM-1) in neutrophil recruitment based on both in-vivo scratch models of bacterial keratitis and bacterial challenged in cell culture models is discussed.

16 citations

Journal ArticleDOI
TL;DR: The present study aims to investigate the antimicrobial as well as antivirulence potential and the principle mechanism of action of guaiacol against Pseudomonas aeruginosa.
Abstract: The present study aims to investigate the antimicrobial as well as antivirulence potential and the principle mechanism of action of guaiacol against Pseudomonas aeruginosa.

3 citations

Journal ArticleDOI
TL;DR: In this article , the authors identify the aerobic bacterial isolates and determine corresponding antibiotic susceptibility profiles in vitro in canine clinical specimens with stromal corneal ulcers, with the goal of providing recommendations for first-line treatment with antibiotics.
Abstract: Simple Summary Infection of the cornea is among the most frequent causes for the loss of vision in dogs. The purpose of this study was to determine which particular antibiotics can be used immediately at the time of infection to eliminate bacteria from the infected region and prevent the loss of the eye. This study showed that combinations of antibiotics (amikacin and neopolybac or ofloxacin and neopolybac) are potentially the best first choice of treatment to eliminate the majority of commonly isolated bacteria from corneal infections in dogs. Abstract The aim of the study was to identify the aerobic bacterial isolates and determine corresponding antibiotic susceptibility profiles in vitro in canine clinical specimens with stromal corneal ulcers, with the goal of providing recommendations for first-line treatment with antibiotics. A total of 198 canine corneal stromal ulcer samples were studied between 2018 and 2021. A corneal swab was collected and cultured under aerobic conditions. Bacterial organisms were identified at the species level by MALDI-TOF mass spectrometry. Antibiotic susceptibility testing for commonly used topical and systemic antibiotics was performed by disk diffusion. Bacterial growth was obtained from 80% of samples. A variety of bacterial species were identified wherein the most common specimens were represented by Staphylococcus pseudintermedius (22%), Staphylococcus epidermidis (12%), Staphylococcus capitis (11%), and Pseudomonas aeruginosa (10%). Based on the overall antibiotic susceptibility data, neopolybac alone (96%) or a combination of neopolybac with either ofloxacin or amikacin (each 99%) showed the best coverage for commonly isolated bacterial organisms from canine corneal stromal ulcers. Results of this study support the use of the combined antibiotics as the first-line response for the treatment of canine corneal stromal ulcers. A statically significant increase in acquired bacterial resistance was detected during the longitudinal data observation.

2 citations

Journal ArticleDOI
TL;DR: 0.66% povidone iodine added to the antimicrobial treatment of a corneal abscess caused by Pseudomonas aeruginosa was effective, safe, and well tolerated in treating ocular infection caused by P. aerug in a contact lens wearer.
Abstract: Contact lens use is often associated with corneal infections. Pseudomonas aeruginosa is the most common cause of contact lens-associated infections. Its treatment is often challenging due to the ability of this opportunistic bacteria to be resistant to antibiotics that are, usually, prescribed empirically. Antiseptic could be an adjunctive therapy aiming to broaden the antimicrobial spectrum. Low concentration povidone iodine has rapid broad-spectrum activity against bacteria including P. aeruginosa, fungi, viruses, protozoa, and biofilms, lack of resistance and efficacy in wound healing process, along with an optimum safety and tolerability profile. The purpose of this case report was to show the effect of 0.66% povidone iodine added to the antimicrobial treatment of a corneal abscess caused by P. aeruginosa in a contact lens wearer. A 25-year-old female, with suspected microbial keratoconjunctivitis was empirically treated with topical antibiotics (gentamicin and moxifloxacin). After a worsening of the corneal abscess, subconjunctival injection of gentamicin was started and, with the aim of broadening the antimicrobial spectrum, 0.66% PVP-I (2 times a day) was added. Based on the antibiogram, registering abundant growth of P. aeruginosa, topical antibiotics were substituted with ciprofloxacin, while PVP-I was maintained until complete recovery. Combined treatment of antibiotics and PVP-I 0.66% was effective, safe, and well tolerated in treating ocular infection caused by P. aeruginosa. PVP-I could be a useful additional therapeutic tool for fighting P. aeruginosa infections, generally resistant to antibiotics, and to prevent clinical worsening pending the correct microbiological diagnosis.

2 citations

References
More filters
Journal ArticleDOI
TL;DR: The recent overuse of fluoroquinolone has led to both increased resistance and enhanced virulence of carbapenem-resistant P. aeruginosa, and data indicate a specific relationship among exoU genotype, fluoroequilibrium resistance, and resistance-conferring mutations.
Abstract: Background Pseudomonas aeruginosa is a clinically important pathogen that causes opportunistic infections and nosocomial outbreaks. Recently, the type III secretion system (TTSS) has been shown to play an important role in the virulence of P. aeruginosa. ExoU, in particular, has the greatest impact on disease severity. We examined the relationship among the TTSS effector genotype (exoS and exoU), fluoroquinolone resistance, and target site mutations in 66 carbapenem-resistant P. aeruginosa strains.

40 citations


Additional excerpts

  • ...aeruginosa in ocular infections [67-77]....

    [...]

Journal ArticleDOI
TL;DR: It is shown that qnrVC has already emerged worldwide out of the Vibrionaceae family in bacterial species of public health relevance, and in association with mobile genetic elements.
Abstract: The quinolones are antibiotics effective in the treatment of several current nosocomial infections. Bacteria carrying qnr genes present with decreased susceptibility to fluoroquinolones. In addition to this low-level resistance, qnr genes are associated with reduced bactericidal activity of ciprofloxacin in vitro and in vivo, which represents a therapeutic threat (Allou et al., 2009). Moreover, in association with mutations in gyrA/parC and with efflux pump regulatory systems, a full fluoroquinolone resistance phenotype can easily emerge, resulting in treatment failure (Rodrı́guezMartı́nez et al., 2011). Recently, due to increasing reports of qnrVC alleles in different genetic contexts, these genes were classified within a new transferable qnr family (Pons et al., 2013). Here, using in silico analysis, we show that qnrVC has already emerged worldwide out of the Vibrionaceae family in bacterial species of public health relevance, and in association with mobile genetic elements.

36 citations


Additional excerpts

  • ..., and Acinetobacter spp [65]....

    [...]

Journal ArticleDOI
TL;DR: This is the first known description of a qnr determinant in a P. aeruginosa strain harbouring aqnrVC1 cassette and a new group IIC-attC intron, which might favour the emergence of highly resistant mutants.
Abstract: Objectives A burn unit of a hospital in Tunis underwent an endemic situation caused by imipenem-resistant Pseudomonas aeruginosa. For nine non-repetitive isolates of a clonal VIM-2-producing strain, the blaVIM-2 genetic background was characterized and the associated qnrVC1 gene molecularly analysed. Methods The imipenem resistance mechanism was investigated by phenotypic and molecular tests, and resistance transfer was studied by conjugation and transformation experiments. The integron's structure was characterized by sequencing, and qnrVC1 expression was explored after cloning experiments. Results The nine VIM-2-producing strains were collected from eight patients and one environmental sample. All transfer assays failed, suggesting a chromosomal location of blaVIM-2. This latter was found to be part of a class 1 integron of ∼7500 bp, which also contains blaOXA-2, aadA1 and two copies of the aadB, arr-6 and qnrVC1 genes. qnrVC1 exhibited higher homology with the chromosomally encoded qnr genes of Vibrionaceae than with plasmid-mediated qnr genes of Enterobacteriaceae. The qnrVC1 gene cassette possesses a promoter allowing its expression, and it conferred decreased fluoroquinolone susceptibility to Escherichia coli. Additionally, on the same integron, genes encoding an uncommon group IIC-attC intron were detected. Conclusions A VIM-2-producing P. aeruginosa outbreak led us to characterize an integron harbouring a qnrVC1 cassette and a new group IIC-attC intron. This is the first known description of a qnr determinant in a P. aeruginosa strain. Its presence conferred a low level of resistance to quinolones in E. coli, which might favour the emergence of highly resistant mutants.

32 citations


"Acquired fluoroquinolone resistance..." refers background in this paper

  • ...aeruginosa strains isolated between 2007 and 2012 [21, 54]....

    [...]

Journal ArticleDOI
TL;DR: To attempt to predict AMR from whole genomes using two different methods and determine whether this panel could be an informative complement to the international P. aeruginosa reference panel, the main goals were to sequence and compare these strains' genomes, and to urge caution in the interpretation of predicted resistomes regarding the occurrence of gene identity discrepancies between strains.
Abstract: Antimicrobial resistance (AMR) is now recognized as a global threat to human health. The accessibility of microbial whole-genome sequencing offers an invaluable opportunity for resistance surveillance via the resistome, i.e. the genes and mutations underlying AMR. Unfortunately, AMR prediction from genomic data remains extremely challenging, especially for species with a large pan-genome. One such organism, for which multidrug-resistant (MDR) isolates are frequently encountered in the clinic, is Pseudomonas aeruginosa. This study focuses on a commercially available panel of seven MDR P. aeruginosa strains. The main goals were to sequence and compare these strains' genomes, attempt to predict AMR from whole genomes using two different methods and determine whether this panel could be an informative complement to the international P. aeruginosa reference panel. As expected, the results highlight the complexity of associating genotype and AMR phenotype in P. aeruginosa, mainly due to the intricate regulation of resistance mechanisms. Our results also urge caution in the interpretation of predicted resistomes regarding the occurrence of gene identity discrepancies between strains. We envision that, in addition to accounting for the genomic diversity of P. aeruginosa, future development of predictive tools will need to incorporate a transcriptomic, proteomic and/or metabolomic component.

31 citations


"Acquired fluoroquinolone resistance..." refers result in this paper

  • ...Similar to previous reports [23, 36, 44, 45], the phylogenetic tree based on the core genome revealed two major clades (Fig 1)....

    [...]

Journal ArticleDOI
TL;DR: This first investigation into potential differences in fitness costs of FQ-resistance that are linked to the virulence genotype of P. aeruginosa found that exoU strains may be able to compensate for the fitness costs associated with the mutation through better regulation of supercoiling compared to the exoS strains.
Abstract: Fluoroquinolone (FQ) resistance is highly prevalent among clinical strains of Pseudomonas aeruginosa, limiting treatment options. We have reported previously that highly virulent strains containing the exoU gene of the type III secretion system are more likely to be FQ-resistant than strains containing the exoS gene, as well as more likely to acquire resistance-conferring mutations in gyrA/B and parC/E. We hypothesize that FQ-resistance imposes a lower fitness cost on exoU compared to exoS strains, thus allowing for better adaptation to the FQ-rich clinical environment. We created isogenic mutants containing a common FQ-resistance conferring point mutation in parC from 3 exoU and 3 exoS clinical isolates and tested fitness in vitro using head-to-head competition assays. The mutation differentially affected fitness in the exoU and exoS strains tested. While the addition of the parC mutation dramatically increased fitness in one of the exoU strains leaving the other two unaffected, all three exoS strains displayed a general decrease in fitness. In addition, we found that exoU strains may be able to compensate for the fitness costs associated with the mutation through better regulation of supercoiling compared to the exoS strains. These results may provide a biological explanation for the observed predominance of the virulent exoU genotype in FQ-resistant clinical subpopulations and represent the first investigation into potential differences in fitness costs of FQ-resistance that are linked to the virulence genotype of P. aeruginosa. Understanding the fitness costs of antibiotic resistance and possibilities of compensation for these costs is essential for the rational development of strategies to combat the problem of antibiotic resistance.

30 citations


Additional excerpts

  • ...aeruginosa in ocular infections [67-77]....

    [...]

Related Papers (5)